Molecular testing
| Molecular testing | |
|---|---|
| Term | Molecular testing |
| Short definition | molecular risk assessment - (pronounced) (muh-LEH-kyoo-ler risk uh-SES-ment) A technique that uses biomarkers (such as biological molecules or changes in the DNA of tumor cells) to estimate a person's risk of developing cancer. Specific biomarkers can be associated with certain types of cancer |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
molecular testing - (pronounced) (muh-LEH-kyoo-ler TES-ting) laboratory method that uses a sample of tissue, blood, or other body fluid to look for specific genes, proteins, or other molecules that can be a sign of a disease or condition, such as cancer. Molecular testing can also be used to look for specific changes in a gene or chromosome that can increase a person's risk of developing cancer or other diseases. Molecular testing can be done with other procedures, such as biopsies, to help diagnose some types of cancer. It can also be used to plan treatment, find out how well treatment is working, make a prognosis, or predict whether the cancer will come back or spread to other parts of the body. Also called biomarker testing and molecular profiling
External links
- Medical encyclopedia article on Molecular testing
- Wikipedia's article - Molecular testing
This MedicineGPT article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski